Induction of inducible nitric oxide synthase and its corresponding tetrahydrobiopterin-cofactor-synthesizing enzyme GTP-cyclohydrolase I during cutaneous wound repair

被引:85
作者
Frank, S
Madlener, M
Pfeilschifter, J
Werner, S
机构
[1] Univ Frankfurt Klinikum, Zentrum Pharmakol, Inst Allgemeine Pharmakol & Toxikol, D-60590 Frankfurt, Germany
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
keratinocytes; vascular endothelial growth factor;
D O I
10.1046/j.1523-1747.1998.00434.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Recent work has suggested a possible role of nitric oxide, a free radical gas, during the wound healing process. In this study we investigated the regulation of inducible nitric oxide synthase (iNOS) and GTP-cyclohydrolase I(GTP-CH I), the rate-limiting enzyme in the biosynthesis of the iNOS cofactor (6R) 5,6,7,8-tetrahydrobiopterin (6-BH4), during the repair process. We found a similar time course of induction of iNOS and GTP-CH I expression, whereas absolute expression levels were different for both genes. Immunohistochemical analysis revealed colocalization of iNOS and GTP-CH I proteins in the wound. Systemic treatment with glucocorticoids significantly altered the expression levels of iNOS and GTP-CH I, Expression iNOS and GTP-CH I was suppressed by glucocorticoids in normal, and to a much greater extent in wounded skin. Furthermore, a role of nitric oxide as a novel mediator of gene regulation during healing is suggested by the demonstration of nitric oxide-mediated induct-ion of vascular endothelial growth factor expression in keratinocytes. These findings may provide an explanation for the beneficial effects of orally supplemented L-arginine on wound healing, and suggest that a disturbed induction of iNOS and GTP-CH I expression may at least partially underlie the wound healing defect seen in glucocorticoid-treated animals.
引用
收藏
页码:1058 / 1064
页数:7
相关论文
共 58 条
[1]  
ALBINA JE, 1990, J IMMUNOL, V144, P3877
[2]  
BAEK KJ, 1993, J BIOL CHEM, V268, P21120
[3]  
BARBUL A, 1990, SURGERY, V108, P331
[4]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[5]   SUPPRESSION OF KERATINOCYTE GROWTH-FACTOR EXPRESSION BY GLUCOCORTICOIDS IN-VITRO AND DURING WOUND-HEALING [J].
BRAUCHLE, M ;
RASSLER, R ;
WERNER, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (04) :579-584
[6]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[7]   A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes [J].
BruchGerharz, D ;
Fehsel, K ;
Suschek, C ;
Michel, G ;
Ruzicka, T ;
KolbBachofen, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :2007-2012
[8]   Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells [J].
Chin, K ;
Kurashima, Y ;
Ogura, T ;
Tajiri, H ;
Yoshida, S ;
Esumi, H .
ONCOGENE, 1997, 15 (04) :437-442
[9]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[10]  
Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3